ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Account Payables
Amounts the company owes suppliers for goods and services received.
Account Payables history
Currency unavailable · from the balance sheet
No Account Payables data reported for this period type.
Account Payables vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $19.06M USD | +32.8% | -2.5% | 3.3% | |
| Mar 2026 | $16.66M USD | -17.9% | -15.4% | 6.8% | |
| Mar 2026 | $12.33M USD | +22.9% | +27.1% | 4.2% | |
| Mar 2026 | $10.37M USD | -44.9% | +11.4% | 9.0% | |
| Mar 2026 | $6.84M USD | +212.9% | +86.1% | 1.5% | |
| Mar 2026 | $4.09M USD | -33.8% | -17.2% | 1.7% | |
| Mar 2026 | $807K USD | — | — | 0.3% | |
| Mar 2026 | $635K USD | +46.7% | -21.9% | 0.3% | |
| Mar 2026 | €189.2K EUR | -57.7% | -8.7% | 0.2% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | +2.5% | -5.6% | 1.7% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.